JPMorgan Chase & Co’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-7,821
| Closed | -$411K | – | 5301 |
|
2020
Q3 | $411K | Sell |
7,821
-1,788
| -19% | -$94K | ﹤0.01% | 3459 |
|
2020
Q2 | $589K | Sell |
9,609
-619
| -6% | -$37.9K | ﹤0.01% | 3242 |
|
2020
Q1 | $579K | Sell |
10,228
-326
| -3% | -$18.5K | ﹤0.01% | 3235 |
|
2019
Q4 | $601K | Sell |
10,554
-9,317
| -47% | -$531K | ﹤0.01% | 3336 |
|
2019
Q3 | $1.06M | Buy |
19,871
+8,188
| +70% | +$438K | ﹤0.01% | 3038 |
|
2019
Q2 | $701K | Buy |
11,683
+1,220
| +12% | +$73.2K | ﹤0.01% | 3212 |
|
2019
Q1 | $653K | Buy |
10,463
+6,152
| +143% | +$384K | ﹤0.01% | 3242 |
|
2018
Q4 | $261K | Buy |
4,311
+2,978
| +223% | +$180K | ﹤0.01% | 3686 |
|
2018
Q3 | $78K | Buy |
1,333
+435
| +48% | +$25.5K | ﹤0.01% | 4201 |
|
2018
Q2 | $40K | Sell |
898
-240
| -21% | -$10.7K | ﹤0.01% | 4388 |
|
2018
Q1 | $50K | Sell |
1,138
-81
| -7% | -$3.56K | ﹤0.01% | 4148 |
|
2017
Q4 | $53K | Buy |
+1,219
| New | +$53K | ﹤0.01% | 4117 |
|
2016
Q3 | – | Sell |
-966
| Closed | -$39K | – | 4356 |
|
2016
Q2 | $39K | Buy |
966
+853
| +755% | +$34.4K | ﹤0.01% | 3602 |
|
2016
Q1 | $4K | Buy |
113
+39
| +53% | +$1.38K | ﹤0.01% | 3929 |
|
2015
Q4 | $3K | Buy |
+74
| New | +$3K | ﹤0.01% | 3865 |
|